Everolimus for patients with mantle cell lymphoma refractory to or intolerant of bortezomib: Multicentre, single-arm, phase 2 study

Michael Wang, Leslie L. Popplewell, Robert H. Collins, Jane N. Winter, Andre Goy, Mark S. Kaminski, Nancy L. Bartlett, Patrick B. Johnston, John Lister, Suzanne R. Fanning, Joseph M. Tuscano, J. Thaddeus Beck, Hakan Kaya, Anna Robeva, Jenna Fan, Judith Klimovsky, Wing Cheung, Azzeddine Cherfi, Owen A. O'Connor*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

38 Scopus citations

Fingerprint

Dive into the research topics of 'Everolimus for patients with mantle cell lymphoma refractory to or intolerant of bortezomib: Multicentre, single-arm, phase 2 study'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science